MedTrace Logo

Cardiac Output Autonomic Stimulation Therapy for Heart Failure (COAST-HF) - Human NeuroCatheter Study

NCT02880683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2016-10-13

No results posted yet for this study

Summary

A single-center feasibility study in patients undergoing cardiac catheterization, to investigate the acute hemodynamic effects of transvenous cardiac autonomic nerve stimulation.

Conditions

  • Cardiac Output, Low

Interventions

DEVICE

NeuroTronik CANS Therapy System

Sponsors & Collaborators

  • NeuroTronik Inc.

    lead INDUSTRY

Principal Investigators

  • Adrian Ebner, Medical Doctor · Facultad de Ciencias Medicas UNA Paraguay, Asuncion, Paraguay

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Paraguay

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02880683 on ClinicalTrials.gov